Mrv1909 05201914342D 18 19 0 0 1 0 999 V2000 0.1067 4.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6078 4.3527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6078 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 3.1152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 2.2902 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.6548 1.8053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9097 1.0206 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.4248 0.3532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7604 -0.4005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7347 1.0206 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.2197 0.3532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.9897 1.8053 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.7743 2.0602 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7512 3.1152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 4.3527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 4.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 5.5902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 5 4 1 6 0 0 0 5 6 1 0 0 0 0 7 6 1 0 0 0 0 7 8 1 6 0 0 0 8 9 1 0 0 0 0 10 7 1 0 0 0 0 10 11 1 1 0 0 0 10 12 1 0 0 0 0 12 5 1 0 0 0 0 12 13 1 6 0 0 0 4 14 1 0 0 0 0 14 15 2 0 0 0 0 14 16 1 0 0 0 0 16 17 1 0 0 0 0 2 17 1 0 0 0 0 17 18 2 0 0 0 0 M ISO 1 13 18 M END > DB14913 > drugbank > CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2[18F])C(=O)NC1=O > InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m1/s1/i11-1 > GBBJCSTXCAQSSJ-MSYRQUNGSA-N > C10H13FN2O5 > 259.224 > 259.083384194 > 5 > 31 > 23.16853261205165 > 1 > 3 > 0 > 0 > 1-[(2R,3S,4R,5R)-3-(¹⁸F)fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione > -0.72 > -1.1285998783333329 > -0.47 > 0 > 2 > 0 > 12.736995396828613 > 10.104350675704374 > -2.9805440359948054 > 99.1 > 55.2306 > 2 > 1 > 8.77e+01 g/l > (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.0^{2,6}.0^{8,18}.0^{12,17}]nonadeca-1(18),8,12(17),13,15-pentaen-11-one > 0 > DB14913 > investigational > 5-methyl-2'-fluoroarauracil F-18 > 18F-FMAU $$$$